Invokamet XR for the Treatment of Type 2 Diabetes in Adults
Developed by Janssen Pharmaceuticals, Invokamet XR (Canagliflozin / Metformin Hydrochloride Extended Release) is indicated for the treatment of Type 2 diabetes in adults.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Canagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Invokana | Metformin | Pharmaceuticals